Biosplice Announces Collaboration with Novo Nordisk in Diabetes Biosplice enters into a pre-clinical collaboration with Novo Nordisk to develop inhibitors of DYRK for diabetes

Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program Biosplice announced today that its collaboration with The Roskamp Institute has been awarded funding by the US Department of Defense.